시장보고서
상품코드
1422075

나노바이오테크놀러지 시장 : 유형별, 치료법별, 기술별, 용도별, 최종사용자별, 지역별, 기회 및 예측(2017-2031년)

Nanobiotechnology Market Assessment, By Type, By Therapeutics, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

발행일: | 리서치사: Market Xcel - Markets and Data | 페이지 정보: 영문 228 Pages | 배송안내 : 3-5일 (영업일 기준)


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

세계 나노바이오테크놀러지 시장 규모는 2023년 758억 달러로 평가되고 2031년에는 1,431억 달러에 달할 것으로 예상되며, 2024년부터 2031년까지 예측 기간 동안 8.27%의 CAGR을 기록할 것으로 예상됩니다. 기술 발전은 세계 나노바이오테크놀러지 시장의 성장을 촉진하고, 연구 개발 투자를 확대하며, 의료 및 의료 분야의 응용을 확대하고, 개인 맞춤형 의료 및 정확한 약물전달 시스템의 필요성을 증가시킬 것입니다. 또한 나노기술과 생명공학의 융합은 진단, 치료, 생물 의학 연구의 진보를 촉발시켜 시장 확대에 크게 기여하고 있습니다.

세계 나노바이오테크놀러지 시장의 견조한 성장은 여러 가지 매우 중요한 요인에 의존하고 있습니다. 가장 중요한 것은 현재 진행 중인 기술 발전이 끊임없이 기술 혁신의 한계를 넓혀가고 있다는 점입니다. 나노 스케일 과학과 공학의 혁신은 나노바이오테크놀러지 분야에서 새로운 도구와 방법론의 출현을 촉진하고 비교할 수 없는 기회를 열어주고 있습니다. 동시에 다양한 분야의 연구 개발(R&D)에 대한 투자가 증가하면서 나노바이오테크놀러지의 진화를 촉진하고 있습니다. 이러한 대규모 투자는 새로운 응용 분야, 재료 및 연구 방법의 탐색을 촉진하고, 헬스케어 및 의료 분야에서 획기적인 발견의 가능성을 높이고 있습니다. 헬스케어 및 의료 분야에서 나노기술의 통합이 증가함에 따라 세계 나노바이오테크놀러지 시장 확대의 원동력이 되고 있습니다.

이러한 분야에서 나노기술의 적응성은 진단 분야에서 놀라운 발전을 촉진하고, 질병을 조기에 발견할 수 있는 민감하고 정확한 도구를 제공합니다. 또한, 치료 분야에서 나노기술은 약물전달 시스템을 변화시켜 약물 방출을 표적화하고 제어함으로써 부작용을 최소화하면서 치료 효과를 향상시킬 수 있습니다. 맞춤형 의료와 정확한 약물전달 시스템에 대한 수요 증가는 세계 나노바이오테크놀러지 시장의 성장을 더욱 촉진하고 있습니다. 나노기술의 치료 및 개입을 맞춤화할 수 있는 능력은 이러한 수요 증가와 완벽하게 일치하며, 개인의 명확한 유전적 구성과 특정 건강 상태에 맞는 치료법 개발을 촉진하고 있습니다. 또한, 나노기술과 생명공학의 융합은 진단, 치료 및 생의학 연구 분야에서 획기적인 발전을 촉진하는 촉매제 역할을 할 수 있습니다. 이러한 융합은 혁신을 촉진하고 나노바이오테크놀러지의 잠재적 영역을 확대하여 세계 나노바이오테크놀러지 시장의 확대와 발전에 크게 기여하고 있습니다.

이 보고서는 세계 나노바이오테크놀러지 시장을 조사하여 시장 개요와 함께 유형별, 치료법별, 기술별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 조사 방법

제2장 프로젝트 범위와 정의

제3장 주요 요약

제4장 세계의 나노바이오테크놀러지 시장 전망, 2017-2031년

  • 시장 규모와 예측
  • 유형별
  • 치료법별
  • 기술별
  • 용도별
  • 최종사용자별
  • 지역별
  • 기업별 시장 점유율(%), 2023년

제5장 세계의 나노바이오테크놀러지 시장 전망, 지역별, 2017-2031년

  • 북미
  • 유럽
  • 남미
  • 아시아태평양
  • 중동 및 아프리카

제6장 시장 매핑, 2023년

제7장 거시적 환경과 산업 구조

  • 수급 분석
  • 수출입 분석
  • 밸류체인 분석
  • PESTEL 분석
  • Porter's Five Forces 분석

제8장 시장 역학

제9장 규제 프레임워크와 혁신

제10장 주요 진출 기업 상황

제11장 가격 분석

제12장 사례 연구

제13장 주요 기업 전망

  • Moderna, Inc.
  • Generation Bio Co.
  • Sanofi S.A.
  • GlaxoSmithKline Plc
  • Arrowhead Pharmaceuticals Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co. Inc.
  • BlueWillow Biologics, Inc.
  • pSivida Corp.
  • Merck KGaA
  • Starpharma Holdings Ltd.
  • Thermo Fisher Scientific Inc.

제14장 전략적 제안

제15장 문의와 면책사항

ksm 24.02.19

Global nanobiotechnology market size was valued at USD 75.8 billion in 2023, expected to reach USD 143.1 billion in 2031, with a CAGR of 8.27% for the forecast period between 2024 and 2031F. Technological advancements propel the growth of the global nanobiotechnology market, amplify R&D investments, expand uses in healthcare and medicine, and increase the need for personalized medicine and precise drug delivery systems. Moreover, the merging of nanotechnology and biotechnology has sparked advancements in diagnostics, therapeutics, and biomedical research, contributing significantly to market expansion.

The robust expansion of the global nanobiotechnology market relies on various pivotal factors. Foremost, the ongoing progression of technological advancements continually pushes the boundaries of innovation. Nanoscale science and engineering breakthroughs have unlocked unparalleled opportunities, fostering the emergence of fresh tools and methodologies in the domain of nanobiotechnology. Concurrently, heightened investments in research and development (R&D) across diverse sectors have propelled the evolution of nanobiotechnology. These substantial investments drive explorations into novel applications, materials, and methodologies, amplifying the potential for groundbreaking discoveries in healthcare and medicine. The increasing integration of nanotechnology in healthcare and medicine serves as a linchpin for expanding the global nanobiotechnology market.

Nanotechnology's adaptability in these arenas facilitates notable strides in diagnostics, presenting highly sensitive and precise tools for early disease identification. Additionally, in therapeutics, nanobiotechnology transforms drug delivery systems by enabling targeted and controlled medication release, improving treatment effectiveness while minimizing adverse effects. The rising demand for tailored medicine and precise drug delivery systems further propels the growth of global nanobiotechnology market. Nanotechnology's ability to customize treatments and interventions aligns perfectly with the escalating need, fostering the development of therapies personalized to an individual's distinct genetic composition or specific health conditions. Moreover, the convergence of nanotechnology and biotechnology acts as a catalyst, driving breakthroughs in diagnostics, therapeutics, and biomedical research. This fusion fuel innovation, expanding the realm of possibilities in nanobiotechnology and significantly contributing to the expansion and progression of global nanobiotechnology market.

Expanding Uses in Healthcare and Medicine

The increasing incorporation of nanotechnology in healthcare and medicine is a fundamental catalyst for the growing global nanobiotechnology market. Nanotechnology's application in these domains encompasses diverse advancements, particularly in diagnostics, therapeutics, and biomedical research. In diagnostics, nanomaterials facilitate the development of exceptionally sensitive and precise diagnostic instruments, enabling early disease detection with outstanding accuracy. Nanobiotechnology transforms drug delivery systems regarding therapeutics, heightening effectiveness while reducing side effects through targeted and precise release of medicinal compounds. Moreover, nanoscale materials drive the innovation of novel treatments, encompassing nano-formulations for various illnesses, gene therapy, and advancements in regenerative medicine. The fusion of nanotechnology and biotechnology has spurred breakthroughs in biomedical research, fostering sophisticated tools to examine biological systems at a molecular level. These strides facilitate the creation of pioneering medical solutions, propelling the global nanobiotechnology market by promising to reshape healthcare delivery and improve outcomes on a global scale.

Amplified Research and Development Investments

Augmented research and development funding significantly drives the global nanobiotechnology market forward. These increased investments stimulate innovative research, nurturing progress in nanoscale technologies, materials, and approaches. They spark pivotal advancements in healthcare, leading to the development of accurate diagnostic tools, specialized drug delivery systems, and tailored treatments. Through the amplification of R&D funding, the market gains from heightened innovation, expanding the frontiers of nanobiotechnology to provide groundbreaking solutions for healthcare, medicine, and biomedical research worldwide.

For instance, in July 2023, McGill University stated that it had agreements in place to fund two innovative research projects involving lipid nanoparticles (LNPs) with Moderna, Inc., a biotechnology company that is leading the way in messenger RNA (mRNA) therapies and vaccines. Since LNPs are the main means of delivering mRNA strands to the target cells, they play a crucial role in mRNA therapeutics like vaccinations.

Government Initiatives

Governments globally are proactively executing diverse strategies to drive the advancement of the global nanobiotechnology market. These initiatives involve significant financial commitments directed towards research and development, stimulating progress in nanoscale technologies. Furthermore, governments institute favorable policies, frameworks, and partnerships to propel nanobiotechnology forward. They foster collaborations between academia, industry, and research entities, fostering knowledge sharing and hastening market expansion. Additionally, governments allocate resources towards infrastructure and offer incentives, aiming to promote the uptake and commercial viability of nanobiotechnology. The concerted effort supports its broad-ranging implementation across sectors like healthcare, medicine, agriculture, and environmental sustainability.

For instance, the National Nanotechnology Initiative (NNI) in the United States was requested to receive USD 1.99 billion in the President's 2023 Budget in February 2023. Since the NNI's founding in 2001, the total requested, including the 2023 request, has exceeded USD 40.7 billion. The National Nanotechnology Initiative (NNI) is a research and development (R&D) program of the United States government. In addition to supporting a shared infrastructure, enabling resource leveraging without duplication, and establishing shared goals, priorities, and strategies that support agency-specific missions and activities, the NNI improves interagency coordination of nanoscale R&D.

Use of Nanotechnology in Drug Delivery

The rising need for nanotechnology in delivering drugs serves as a key catalyst driving the growth of global nanobiotechnology market. Nanotechnology's role in drug delivery allows for precise, targeted drug application, improving effectiveness while reducing potential side effects. The growing demand arises from nanoscale materials' ability to encapsulate medications, ensure their safe delivery to precise cells or tissues. Additionally, nanotechnology enables controlled release methods, improving therapeutic results. The increasing dependence on nanotechnology in drug delivery underscores its importance, fostering advancements and growth in the nanobiotechnology market, reshaping medication administration for better healthcare outcomes worldwide. To speed up the development of nucleic acid-based medicines and vaccines, Mana.bio, a biotechnology startup that accelerates programmable drug delivery, for instance, announced its AI-based lipid nanoparticle (LNP) delivery platform in October 2023, underwritten by a USD 19.5 million oversubscribed seed rounds. With the funding, Mana.bio may continue developing its unique, specially designed AI LNP platform, which could potentially lead to the creation of novel treatments for a variety of unmet needs by delivering RNA and gene therapies to extrahepatic tissues in the body in a safer and more efficient manner.

Growing Popularity of Nanoparticles

The increasing requirement for nanoparticles acts as a substantial driving factor in advancing the global nanobiotechnology market. These tiny entities hold a central position across diverse fields, notably in healthcare, medicine, and materials science. Their distinct characteristics facilitate precise drug administration, improving treatment effectiveness while reducing adverse effects. Moreover, nanoparticles find utility in diagnostics, imaging, and various industrial domains. The rising interest in these adaptable particles emphasizes their significance in propelling nanobiotechnology, encouraging breakthroughs that transform healthcare methodologies, advanced material development, and a broad range of industrial applications, thereby impacting the market's growth and development. A benchtop instrument for detailed analysis of lipid nanoparticles and other nano-formulations, for example, is scheduled to be launched in September 2023 by SPARTA Biodiscovery, a spin-out company from Imperial College London. According to Jelle Penders, PhD, co-inventor of Single Particle Automated Raman Trapping Analysis (SPARTA), the instrument is the first to simultaneously identify the composition and size of nano-formulations in an automated and label-free manner.

Future Market Scenario

The global nanobiotechnology market's future holds remarkable promise, driven by ongoing innovations and evolving applications. Nanobiotechnology leads the forefront of scientific advancement, offering revolutionary changes across numerous industries. In healthcare, it facilitates precise drug delivery, personalized medicine, and advanced diagnostics, improving treatments with reduced side effects. Its impact spans environmental remediation, agriculture, electronics, and energy sectors, revolutionizing material science and manufacturing processes. Continual research and development efforts, along with increased global investments, drive market expansion. Advancing technology and interdisciplinary collaborations further unlock nanobiotechnology's potential, addressing previously insurmountable challenges. Moreover, the convergence of nanotechnology, biotechnology, and information technology foretells a new era, where nanobiotechnology becomes pivotal in addressing global health, environmental, and societal concerns. The trajectory signifies a promising and transformative path for the global nanobiotechnology market.

Key Players Landscape and Outlook

Key players in the global nanobiotechnology market proactively participate in collaborative endeavors encompassing strategic alliances, joint research initiatives, and shared investments. Their goal is to collectively leverage resources, expertise, and technological advancements, driving innovation and broadening the horizons of nanobiotechnology applications. These collaborative initiatives allow for the harnessing of complementary strengths, enabling the creation of innovative products and solutions. Furthermore, these partnerships facilitate market exploration across diverse industries and consumer segments, fostering the widespread adoption of nanobiotechnology. It amplifies its influence not only in healthcare, materials science, and environmental sustainability but also in various other domains.

In March 2023, for example, Moderna announced that it had applied for Generation Bio's exclusive stealth cell-targeted lipid nanoparticle (ctLNP) delivery system to find and create non-viral genetic medicines for liver and immune system disorders. This partnership could bring in up to $1.876 billion for Generation Bio. Moderna has obtained the option to license the closed-end DNA (ceDNA) novel build technology from Generation Bio as well as ctLNP.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Nanobiotechnology Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Type
    • 4.2.1. 0-10 Nm
    • 4.2.2. 10-100 Nm
  • 4.3. By Therapeutics
    • 4.3.1. Dental Therapies
    • 4.3.2. Cardiac Therapies
    • 4.3.3. Orthopedic Therapies
    • 4.3.4. Others
  • 4.4. By Technology
    • 4.4.1. Nanocrystals
    • 4.4.2. Nanoparticles
    • 4.4.3. Liposomes
    • 4.4.4. Micelles
    • 4.4.5. Nanotubes
    • 4.4.6. Others
  • 4.5. By Application
    • 4.5.1. Therapeutics
    • 4.5.2. Nano diagnostics
    • 4.5.3. Tissue Engineering
    • 4.5.4. Gene Therapy
    • 4.5.5. Molecular Nanotechnology
    • 4.5.6. Drug Delivery
    • 4.5.7. Food Safety
  • 4.6. By End-user
    • 4.6.1. Pharmaceutical Companies
    • 4.6.2. Research Institutes and Laboratories
    • 4.6.3. Academic Institutions
    • 4.6.4. Others
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. Europe
    • 4.7.3. South America
    • 4.7.4. Asia-Pacific
    • 4.7.5. Middle East and Africa
  • 4.8. By Company Market Share (%), 2023

5. Global Nanobiotechnology Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Type
      • 5.1.2.1. 0-10 Nm
      • 5.1.2.2. 10-100 Nm
    • 5.1.3. By Therapeutics
      • 5.1.3.1. Dental Therapies
      • 5.1.3.2. Cardiac Therapies
      • 5.1.3.3. Orthopedic Therapies
      • 5.1.3.4. Others
    • 5.1.4. By Technology
      • 5.1.4.1. Nanocrystals
      • 5.1.4.2. Nanoparticles
      • 5.1.4.3. Liposomes
      • 5.1.4.4. Micelles
      • 5.1.4.5. Nanotubes
      • 5.1.4.6. Others
    • 5.1.5. By Application
      • 5.1.5.1. Therapeutics
      • 5.1.5.2. Nano diagnostics
      • 5.1.5.3. Tissue Engineering
      • 5.1.5.4. Gene Therapy
      • 5.1.5.5. Molecular Nanotechnology
      • 5.1.5.6. Drug Delivery
      • 5.1.5.7. Food Safety
    • 5.1.6. By End-user
      • 5.1.6.1. Pharmaceutical Companies
      • 5.1.6.2. Research Institutes and Laboratories
      • 5.1.6.3. Academic Institutions
      • 5.1.6.4. Others
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
      • 5.1.7.1.1. Value
      • 5.1.7.1.2. Volume
      • 5.1.7.2. By Type
      • 5.1.7.2.1. 0-10 Nm
      • 5.1.7.2.2. 10-100 Nm
      • 5.1.7.3. By Therapeutics
      • 5.1.7.3.1. Dental Therapies
      • 5.1.7.3.2. Cardiac Therapies
      • 5.1.7.3.3. Orthopedic Therapies
      • 5.1.7.3.4. Others
      • 5.1.7.4. By Technology
      • 5.1.7.4.1. Nanocrystals
      • 5.1.7.4.2. Nanoparticles
      • 5.1.7.4.3. Liposomes
      • 5.1.7.4.4. Micelles
      • 5.1.7.4.5. Nanotubes
      • 5.1.7.4.6. Others
      • 5.1.7.5. By Application
      • 5.1.7.5.1. Therapeutics
      • 5.1.7.5.2. Nano diagnostics
      • 5.1.7.5.3. Tissue Engineering
      • 5.1.7.5.4. Gene Therapy
      • 5.1.7.5.5. Molecular Nanotechnology
      • 5.1.7.5.6. Drug Delivery
      • 5.1.7.5.7. Food Safety
      • 5.1.7.6. By End-user
      • 5.1.7.6.1. Pharmaceutical Companies
      • 5.1.7.6.2. Research Institutes and Laboratories
      • 5.1.7.6.3. Academic Institutions
      • 5.1.7.6.4. Others
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered:

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Type
  • 6.2. By Therapeutics
  • 6.3. By Technology
  • 6.4. By Application
  • 6.5. By End-user
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Moderna, Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Generation Bio Co.
  • 13.3. Sanofi S.A.
  • 13.4. GlaxoSmithKline Plc
  • 13.5. Arrowhead Pharmaceuticals Inc.
  • 13.6. Bristol-Myers Squibb Company
  • 13.7. Merck & Co. Inc.
  • 13.8. BlueWillow Biologics, Inc.
  • 13.9. pSivida Corp.
  • 13.10. Merck KGaA
  • 13.11. Starpharma Holdings Ltd.
  • 13.12. Thermo Fisher Scientific Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제